{ "items": [ "\n\n
\n \n 5 December 2023\n \n
\n\n \n\n \n \n \nWinners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today. Three winners were selected, with the Department of Oncology's Nathalie Lovgren and Iain Tullis winning third place for their entry 'Starry Winter Night'.
\n \n\n\n \n 1 December 2023\n \n
\n\n \n\n \n \n \nTo celebrate the launch of the UK\u2019s first CRUK clinical trials unit dedicated to cancer precision prevention in Oxford, we held a research symposium that highlighted the spectra of Cancer Precision Prevention clinical programmes across the UK.
\n \n\n\n \n 29 November 2023\n \n
\n\n \n\n \n \n \nThe event brought together researchers from across mathematical, statistical, data and biological sciences to discuss the current and future cutting-edge approaches to tissue pathology.
\n \n\n\n \n 22 November 2023\n \n
\n\n \n\n \n \n \nWomen from ethnic minority backgrounds with a personal connection to breast cancer are being asked to join a new group to support a study aiming to improve patients\u2019 experiences.
\n \n\n\n \n 22 November 2023\n \n
\n\n \n\n \n \n \nThe Nuffield Department of Primary Care Health Sciences wins an NIHR award for a new HealthTech Research Centre (HRC) to explore innovative Health Technology to enhance community and primary care.
\n \n\n\n \n 21 November 2023\n \n
\n\n \n\n \n \n \nOxford Cancer is committed to supporting research that responds to the needs of people with cancer. We are working with groups of patients with different cancers to identify the \u2018Top Ten\u2019 issues that matter most to them. These lists of priorities will be shared with our research colleagues.
\n \n\n\n \n 7 November 2023\n \n
\n\n \n\n \n \n \nA recent publication from Audrey G\u00e9rard\u2019s lab looks at how a specific protein, called IFN\u03b3, can coordinate CD8+ T cell responses during a flu infection.
\n \n\n\n \n 3 November 2023\n \n
\n\n \n\n \n \n \nPawel Swietach (Department of Physiology, Anatomy and Genetics) is author on a new Nature Reviews Cancer article on tumour acidosis, published ahead of the centennial of Otto Warburg\u2019s discovery of lactic acidosis in cancers.
\n \n\n\n \n 31 October 2023\n \n
\n\n \n\n \n \n \nOxford\u2019s early detection research was featured at this annual event.
\n \n\n\n \n 30 October 2023\n \n
\n\n \n\n \n \n \nThe deadline for applications for the CRUK Oxford Development Fund has been extended to the 20th November.
\n \n\n\n \n 30 October 2023\n \n
\n\n \n\n \n \n \nIn this blog, Catriona Gilmour Hamilton \u2013 Patient and Public Involvement Manager - discusses why our Patient and Public Involvement team is generating lists of the \u2018top ten\u2019 priorities for patients with a range of cancer types, and why they are so crucial for researchers.
\n \n\n\n \n 28 October 2023\n \n
\n\n \n\n \n \n \nWe are recruiting our third intake to study for a DPhil in Cancer Science commencing in October 2024.
\n \n\n\n \n 24 October 2023\n \n
\n\n \n\n \n \n \nDr Robert Watson has won one of three McElwain and President's Prizes from the Association of Cancer Physicians for his DPhil work undertaken with Professor Ben Fairfax.
\n \n\n\n \n 23 October 2023\n \n
\n\n \n\n \n \n \nSerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
\n \n\n\n \n 19 October 2023\n \n
\n\n \n\n \n \n \nThe Oxford Translational Myeloma Centre (OTMC) will be a collective force of research, outreach and patient care that will transform treatment opportunities for multiple myeloma cancer patients.
\n \n\n\n \n 17 October 2023\n \n
\n\n \n\n \n \n \nEileen Parkes, Associate Professor in Innate Tumour Immunology in the Department of Oncology, will lead the expansion of the centre\u2019s programmes in early drug development and biomarker research.
\n \n\n\n \n 6 October 2023\n \n
\n\n \n\n \n \n \nAn agreement between Satisfai Health Inc and the University of Oxford will progress the automated assessment of Barrett\u2019s oesophagus with the aim of determining patients most at risk of developing oesophageal cancer.
\n \n\n\n \n 5 October 2023\n \n
\n\n \n\n \n \n \nOxford Cancer and the Kennedy Trust for Rheumatology are pleased to invite you to our joint open day for any medical students interested in pursuing a DPhil in the fields of Cancer Science or Musculoskeletal Disease, Inflammation and Immunology respectively.
\n \n\n\n \n 25 September 2023\n \n
\n\n \n\n \n \n \nResearchers at NDORMS have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.
\n \n\n\n \n 25 September 2023\n \n
\n\n \n\n \n \n \nCongratulations to James Chettle, Masato Inoue and Eoghan Mulholland who have been awarded OxCODE funds to attend this year\u2019s Early Detection of Cancer conference in London.
\n \n\n